ClinicalTrialStartPulse: Phase 3, page 4 of 4
Records 351 to 500 of the 500 newest listed for this hub. Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
| Record | Phase | Conditions | Enrollment |
|---|---|---|---|
| European Group for Research In Schizophrenia | Phase 3 | Schizophrenia; Psychosis; Cognitive Impairment | |
| American Hospital 2 Kosovo | Phase 3 | Infertility, Female | |
| Waterstone Pharmaceutical (Wuhan) Co., LTD. | Phase 3 | Hyperkalemia | 300 |
| Pfizer | Phase 3 | Advanced Malignancies; NSCLC; Ovarian Cancer; Urothelial Cancer; Solid Tumors | 77 |
| Jiangsu Simcere Pharmaceutical Co., Ltd. | Phase 3 | Myelosuppression | 106 |
| R-Pharm | Phase 3 | Familial Mediterranean Fever; FMF | 18 |
| Beeline Medicines Corporation | Phase 3 | Cutaneous Lupus Erythematosus (CLE); Systematic Lupus Erythematosus | 390 |
| AbbVie | Phase 3 | Skin Quality | 150 |
| Shanghai RAAS Blood Products Co., Ltd. | Phase 3 | Hemophilia A; Hemophilia A and B; Hemophilia B | 90 |
| SystImmune Inc. | Phase 3 | Urothelial Cancer; Metastatic Urothelial Cancer; Bladder Cancer; Bladder Cancer (BC); Bladder (Urothelial, Transitional Cell) Cancer; Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable | 520 |
| Astellas Pharma Global Development, Inc. | Phase 3 | Chronic Kidney Disease; Renal Anemia | 98 |
| Sanofi | Phase 3 | Chronic Rhinosinusitis With Nasal Polyps | 59 |
| 4D Molecular Therapeutics | Phase 3 | Diabetic Macular Edema (DME) | 514 |
| Pfizer | Phase 3 | Asthma | 1100 |
| Kyowa Kirin Co., Ltd. | Phase 3 | Achondroplasia | 13 |
| Sagimet Biosciences Inc. | Phase 3 | Acne Vulgaris | 800 |
| GlaxoSmithKline | Phase 3 | Pruritus | 40 |
| Taisho Pharmaceutical Co., Ltd. | Phase 3 | Hyperphosphatemia Patients on Hemodialysis | 34 |
| Ambros Therapeutics, Inc. | Phase 3 | Complex Regional Pain Syndrome Type I | 135 |
| Zhejiang Hanmai Pharmaceutical Technology Co., Ltd. | Phase 3 | Diabetic Peripheral Neuropathic Pain (DPNP) | 400 |
| Intra-Cellular Therapies, Inc. | Phase 3 | Generalized Anxiety Disorder | 705 |
| JCR Pharmaceuticals Co., Ltd. | Phase 3 | Mucopolysaccharidosis II | 86 |
| Applied Biologics, LLC | Phase 3 | Diabetic Foot Ulcer; Amniotic Membrane Placental Allograft; Biologic | 253 |
| GlaxoSmithKline | Phase 3 | Influenza, Human | 3000 |
| Amgen | Phase 3 | Glomerulonephritis, Membranous | 159 |
| FutureChem | Phase 3 | Prostate Cancer; mCRPC | 114 |
| AstraZeneca | Phase 3 | Epithelial Ovarian Cancer | 950 |
| Astellas Pharma Global Development, Inc. | Phase 3 | Neurogenic Detrusor Overactivity | 7 |
| Hoffmann-La Roche | Phase 3 | Neoplasms | 49 |
| Hoffmann-La Roche | Phase 3 | Moderately to Severely Active Ulcerative Colitis | 350 |
| CANbridge Life Sciences Ltd. | Phase 3 | Gaucher Disease; Gaucher Disease Type 1; Gaucher Disease Type 3 | 10 |
| Pfizer | Phase 3 | Obesity; Overweight and/or Obesity; Overweight; Treatment Of Obesity | 660 |
| Chengdu Suncadia Medicine Co., Ltd. | Phase 3 | Slowing the Progression of Myopia in Children | 509 |
| Adneuris Therapeutics, Inc. | Phase 3 | Pain | 160 |
| Hoffmann-La Roche | Phase 3 | Obesity or Overweight; Type 2 Diabetes | 600 |
| Hoffmann-La Roche | Phase 3 | Obesity or Overweight | 3900 |
| Hoffmann-La Roche | Phase 3 | Obesity or Overweight; Cardiovascular Disease | 2500 |
| Ultragenyx Pharmaceutical Inc | Phase 3 | Osteogenesis Imperfecta | 6 |
| Price Vision Group | Phase 3 | Keratoconus; Corneal Ectasia | 500 |
| MeiraGTx Ocular UK Ltd | Phase 3 | Retinitis Pigmentosa | 4 |
| MeiraGTx Ocular UK Ltd | Phase 3 | X-Linked Retinitis Pigmentosa | 97 |
| Hoffmann-La Roche | Phase 3 | Hemophilia A | 50 |
| Harrow Inc | Phase 3 | Postoperative Ocular Inflammation; Postoperative Ocular Pain | 250 |
| AbbVie | Phase 3 | Hepatocellular Carcinoma | 89 |
| Lantheus Medical Imaging | Phase 3 | Prostate Cancer | 408 |
| Astellas Pharma Inc | Phase 3 | Hot Flashes | 100 |
| Hoffmann-La Roche | Phase 3 | Influenza, Human; Respiratory Tract Infections; Post-exposure Prophylaxis | 325 |
| Ultragenyx Pharmaceutical Inc | Phase 3 | Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) | 69 |
| Evopoint Biosciences Inc. | Phase 3 | Pancreatic Cancer | 226 |
| Pfizer | Phase 3 | Apnea; Sleep Disorders; Overweight and/or Obesity | 258 |
| Pfizer | Phase 3 | Atopic Dermatitis | 90 |
| Lipocine Inc. | Phase 3 | Depression, Postpartum; Postpartum Depression (PPD); Post-partum Depression; Postnatal Depression; Post-Natal Depression; Peripartum Depression | 120 |
| Merck Sharp & Dohme LLC | Phase 3 | Hyperlipidemia; Hypercholesterolemia | 150 |
| Novo Nordisk A/S | Phase 3 | Overweight; Obesity | 400 |
| Portal Therapeutics, Inc. | Phase 3 | Erythropoietic Protoporphyria (EPP); X-Linked Protoporphyria (XLP); EPP2 | 225 |
| Pelage Pharmaceuticals, Inc. | Phase 3 | Androgenetic Alopecia | 600 |
| Suzhou Abogen Biosciences Co., Ltd. | Phase 3 | Varicella-zoster Virus | 18000 |
| Novo Nordisk A/S | Phase 3 | Diabetes Mellitus, Type 2 | 210 |
| AstraZeneca | Phase 3 | Platinum-sensitive Relapsed Epithelial Ovarian Cancer; Platinum-sensitive Relapsed Fallopian Tube Cancer; Platinum-sensitive Relapsed Primary Peritoneal Cancer | 600 |
| Pfizer | Phase 3 | Adult; Healthy Participants | 600 |
| Eli Lilly and Company | Phase 3 | Obesity | 150 |
| Cairo University | Phase 3 | Vitiligo; Non-Segmental Vitiligo (NSV); Stable Vitiligo | 35 |
| Tanta University | Phase 3 | Acne | 20 |
| Khyber Teaching Hospital | Phase 3 | Diabetic Macular Edema (DME) | 60 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 3 | Type 1 Diabetes; Overweight , Obesity | 40 |
| Future University in Egypt | Phase 3 | Dental Implant; Wound Healing | 20 |
| Columbia University | Phase 3 | Abdominal Pain; Isolated Extremity Fracture; Pain; Pediatrics | 1010 |
| MELISA Institute Genomics & Proteomics Research SpA | Phase 3 | COVID-19; SARS-CoV2 | |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | Phase 3 | HFpEF - Heart Failure With Preserved Ejection Fraction; TAVI(Transcatheter Aortic Valve Implantation); Finerenone | 2832 |
| Centre Hospitalier Universitaire, Amiens | Phase 3 | Intravenous Lidocaine; Laparoscopic Surgery; Post Operative Recovery; Local Anaesthetic Systemic Toxicity | 182 |
| Sun Yat-sen University | Phase 3 | Nasopharyngeal Cancinoma (NPC) | 204 |
| Shanghai Junshi Bioscience Co., Ltd. | Phase 3 | Diffuse Large B-Cell Lymphoma | 282 |
| Johns Hopkins Bloomberg School of Public Health | Phase 3 | Neurodevelopment Outcome; Linear Growth; Micronutrient Status; Bone Mineral Density; Underweight; Stunting | 3000 |
| University of Oxford | Phase 3 | Psychosis; First Episode Psychosis; Psychotic Disorders; Psychotic Episode | 250 |
| The First Affiliated Hospital of Anhui Medical University | Phase 3 | Acute Ischemic Stroke | 616 |
| Medicines Development for Global Health | Phase 3 | Lymphatic Filariasis; Scabies; Strongyloidiasis | 5100 |
| University Health Network, Toronto | Phase 3 | Bleeding; Platelets; Cardiopulmonary Bypass; Cardiac Surgery | 100 |
| First Affiliated Hospital of Guangxi Medical University | Phase 3 | Acute Ischemic Stroke; Tenecteplase | 352 |
| Centre Hospitalier Universitaire de Nice | Phase 3 | Erosive Hand Osteoarthritis | 170 |
| The First Affiliated Hospital with Nanjing Medical University | Phase 3 | Medium Vessel Occlusion; Ischemic Stroke, Acute | 372 |
| Sarfez Pharmaceuticals, Inc. | Phase 3 | Hypertension (HTN) | |
| Elsan | Phase 3 | Atrial Fibrillation (AF) | 636 |
| West China Hospital | Phase 3 | Colorectal Cancer | 140 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 | Sexually Transmitted Infection (STI); Gonorrhea; Syphilis; Chlamydia | 580 |
| University Health Network, Toronto | Phase 3 | Head and Neck Cancer | 288 |
| Sun Yat-sen University | Phase 3 | Long-term Sedation for Mechanical Ventilation; Critically Ill Intensive Care Unit Patients | 274 |
| VA Office of Research and Development | Phase 3 | Prostate Cancer; Oligometastasis; Oligorecurrence; Recurrent Prostate Cancer; Metastatic Prostate Cancer; De Novo Prostate Cancer | 378 |
| Alliance for Clinical Trials in Oncology | Phase 3 | Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8; HER2 Negative Breast Carcinoma; Hormone Receptor Positive Breast Carcinoma; Invasive Breast Carcinoma | 1167 |
| German Cancer Research Center | Phase 3 | Non-Small Cell Lung Cancer | 406 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 3 | Sudden Sensorineural Hearing Loss (SSNHL) | 146 |
| Fudan University | Phase 3 | Locally Advanced Colon Cancer; pMMR | 480 |
| Assistance Publique - Hôpitaux de Paris | Phase 3 | Antiphospholipid Syndrome; Thrombotic Antiphospholipid Syndrome; Thrombosis | 234 |
| Chestnut Health Systems | Phase 3 | Substance Use Disorder (SUD); Opioid Use Disorders; Stimulant Overdose; Overdose Risk; Alcohol Use Disorder | 600 |
| Beijing VDJBio Co., LTD. | Phase 3 | Anti IL-6R; Castleman's Disease, Multicentric | 45 |
| Oslo University Hospital | Phase 3 | Acute Ischemic Stroke | 156 |
| Children's Oncology Group | Phase 3 | Ganglioneuroblastoma; Localized Resectable Neuroblastoma; Localized Unresectable Neuroblastoma; Neuroblastoma | 391 |
| Shandong Cancer Hospital and Institute | Phase 3 | Newly Diagnosed Triple-negative Breast Cancer | 852 |
| McMaster Children's Hospital | Phase 3 | Appendicitis Perforated; Appendectomy, Laparoscopic; Antibiotic; Pediatric; Randomized Controlled Trial | 180 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 3 | Locally Advanced Pancreatic Carcinoma (LAPC) | 230 |
| Shandong Cancer Hospital and Institute | Phase 3 | Diffuse Intrinsic Pontine Gliomas (DIPG) | 142 |
| UNC Lineberger Comprehensive Cancer Center | Phase 3 | Endometrial Adenocarcinoma; Metastatic Endometrial Cancer; Endometrial Cancer; Recurrent Endometrial Cancer | 140 |
| Nantes University Hospital | Phase 3 | Chronic Pain | 266 |
| Women's Cancer Study Group GmbH | Phase 3 | Breast Cancer Female | 1684 |
| Beijing Tiantan Hospital | Phase 3 | Mild Cognitive Impairment | 144 |
| Swiss Tropical & Public Health Institute | Phase 3 | Trichuris Trichiura; Infection; Hookworm Infection; Ascaris Lumbricoides Infection | 315 |
| Kafrelsheikh University | Phase 3 | Metabolic Dysfunction-Associated Steatoic Liver Disease | 120 |
| M.D. Anderson Cancer Center | Phase 3 | Breast Cancer | 681 |
| Post Graduate Institute of Medical Education and Research, Chandigarh | Phase 3 | Hemophagocytic Lymphohistiocytosis (HLH); Secondary Hemophagocytic Lymphohistiocytosis | 116 |
| M.D. Anderson Cancer Center | Phase 3 | Advanced Malignant Neoplasm; Metastatic Malignant Neoplasm; Recurrent Malignant Neoplasm | 212 |
| Capital Medical University | Phase 3 | Acute Ischemic Stroke | 692 |
| Eastern Cooperative Oncology Group | Phase 3 | Brain and Central Nervous System Tumors; Neurotoxicity | 540 |
| ECOG-ACRIN Cancer Research Group | Phase 3 | Plasma Cell Myeloma | 1087 |
| Wills Eye | Phase 3 | Retinal Detachment Rhegmatogenous | 190 |
| Groupe Oncologie Radiotherapie Tete et Cou | Phase 3 | Head and Neck Squamous Cell Carcinoma | 256 |
| Tata Memorial Hospital | Phase 3 | Operable Breast Cancer | 1600 |
| NRG Oncology | Phase 3 | Grade 2 Meningioma; Intracranial Meningioma | 162 |
| Tata Memorial Hospital | Phase 3 | Triple Negative Breast Cancer | 720 |
| Groupe Oncologie Radiotherapie Tete et Cou | Phase 3 | HNSCC | 707 |
| Groupe Oncologie Radiotherapie Tete et Cou | Phase 3 | Squamous Cell Carcinoma of Head and Neck | 680 |
| ECOG-ACRIN Cancer Research Group | Phase 3 | Metastatic Castration-Resistant Prostate Adenocarcinoma; Stage IVB Prostate Cancer AJCC v8 | 432 |
| Tanta University | Phase 3 | Cardiotoxicity | 140 |
| Woolcock Institute of Medical Research | Phase 3 | Sleep Apnoea; Obesity & Overweight; Sleep Apnea Syndrome, Obstructive | 256 |
| Xinqiao Hospital of Chongqing | Phase 3 | Acute Ischemic Stroke | 1482 |
| Fondazione IRCCS Policlinico San Matteo di Pavia | Phase 3 | Electrical Storm; VT; VF; Ventricular Arrhythmia; Ventricular Tachycardia (VT); Ventricular Fibrillation | 180 |
| Jean-Pierre Van geertruyden | Phase 3 | Ebola Hemorrhagic Fever; Bundibugyo Virus Disease | 3620 |
| Washington University School of Medicine | Phase 3 | Neuroendocrine Neoplasm; Gastroenteropancreatic Neuroendocrine Neoplasm | 240 |
| Alliance for Clinical Trials in Oncology | Phase 3 | Stage II Rectal Cancer AJCC v8; Stage III Rectal Cancer AJCC v8; Locally Advanced Rectal Adenocarcinoma | 760 |
| M.D. Anderson Cancer Center | Phase 3 | Sleep; Fatigue; Anxiety; Cancer; Depression | 169 |
| Jawaharlal Institute of Postgraduate Medical Education & Research | Phase 3 | Major Depressive Episode | 220 |
| Vanderbilt University Medical Center | Phase 3 | Post-operative Pain; DIEP Flap Breast Reconstruction; DIEP Flap; Opioid; Suzetrigine; ERAS | 198 |
| Sindh Institute of Cardiovascular Diseases | Phase 3 | Pulmonary Hypertension; Rheumatic Valvular Heart Disease | 100 |
| University Hospital, Rouen | Phase 3 | Axial or Predominantly Axial SpondyloArthritis With or Without Psoriasis | 150 |
| Tata Memorial Centre | Phase 3 | Radiation Proctitis; Gastrointestinal Hemorrhage; Radiation Injuries | 200 |
| Florida International University | Phase 3 | Attention Deficit Hyerpactivity Disorder | 544 |
| Starship Child Health, Te Toka Tumai Auckland | Phase 3 | Rheumatic Fever; Rheumatic Heart Disease in Children; Acute Rheumatic Fever; Rheumatic Heart Disease | 600 |
| Novo Nordisk A/S | Phase 3 | Haemophilia A | 84 |
| Robert Förster | Phase 3 | Prostate Cancer (Post Prostatectomy); Prostate Cancer; SBRT | 206 |
| Fox Chase Cancer Center | Phase 3 | Surgery; Cancer | 526 |
| caohaotian | Phase 3 | Oral Squamous Cell Carcinoma (OSCC); Head and Neck Squamous Cell Carcinoma; Early-stage Oral Cancer | 300 |
| Mario Negri Institute for Pharmacological Research | Phase 3 | Breast Cancer; Interstitial Lung Disease (ILD) | 244 |
| Assiut University | Phase 3 | Rib Fractures; Acute Pain; Thoracic Trauma | 100 |
| Central Hospital, Nancy, France | Phase 3 | Kidney Transplantation | 132 |
| M.D. Anderson Cancer Center | Phase 3 | Lung Adenocarcinoma; Lung Non-Small Cell Carcinoma; Stage IV Lung Cancer AJCC v8 | 339 |
| Post Graduate Institute of Medical Education and Research, Chandigarh | Phase 3 | Chronic Pulmonary Aspergillosis | 220 |
| Western University, Canada | Phase 3 | Osteoarthritis, Knee | 200 |
| University of Minnesota | Phase 3 | Sexual and Reproductive Health; Disability; Health Knowledge, Attitudes, Practice; Health Education | 412 |
| Mayo Clinic | Phase 3 | Biochemically Recurrent Prostate Carcinoma; Oligometastatic Prostate Carcinoma; Recurrent Prostate Adenocarcinoma; Stage IIB Prostate Cancer AJCC v8; Stage IIC Prostate Cancer AJCC v8; Stage III Prostate Cancer AJCC v8 | 118 |
| Shanghai Junshi Bioscience Co., Ltd. | Phase 3 | Hepatocellular Carcinoma | 560 |
| Ohio State University Comprehensive Cancer Center | Phase 3 | Resectable Liposarcoma; Resectable Soft Tissue Sarcoma; Resectable Undifferentiated Pleomorphic Sarcoma | 228 |
| The HIV Netherlands Australia Thailand Research Collaboration | Phase 3 | HIV-infected Participants With Latent TB Infection in High TB Burden Country | 2500 |
All ClinicalTrialStartPulse record reports